Frailty — INSPIRE: Feasibility of a Community-based Integrated Care Model for Older Adults Living at Home
Citation(s)
Abdi S, Spann A, Borilovic J, de Witte L, Hawley M Understanding the care and support needs of older people: a scoping review and categorisation using the WHO international classification of functioning, disability and health framework (ICF). BMC Geriatr. 2019 Jul 22;19(1):195. doi: 10.1186/s12877-019-1189-9. Review. Erratum in: BMC Geriatr. 2020 Jan 22;20(1):23.
Donovan NJ, Blazer D Social Isolation and Loneliness in Older Adults: Review and Commentary of a National Academies Report. Am J Geriatr Psychiatry. 2020 Dec;28(12):1233-1244. doi: 10.1016/j.jagp.2020.08.005. Epub 2020 Aug 19. Review.
Fuller-Thomson E, Yu B, Nuru-Jeter A, Guralnik JM, Minkler M Basic ADL disability and functional limitation rates among older AMERICANS from 2000-2005: the end of the decline? J Gerontol A Biol Sci Med Sci. 2009 Dec;64(12):1333-6. doi: 10.1093/gerona/glp130. Epub 2009 Sep 1.
Looman WM, Huijsman R, Fabbricotti IN The (cost-)effectiveness of preventive, integrated care for community-dwelling frail older people: A systematic review. Health Soc Care Community. 2019 Jan;27(1):1-30. doi: 10.1111/hsc.12571. Epub 2018 Apr 17.
Malterud K, Siersma VD, Guassora AD Sample Size in Qualitative Interview Studies: Guided by Information Power. Qual Health Res. 2016 Nov;26(13):1753-1760. doi: 10.1177/1049732315617444. Epub 2016 Jul 10.
Neta G, Brownson RC, Chambers DA Opportunities for Epidemiologists in Implementation Science: A Primer. Am J Epidemiol. 2018 May 1;187(5):899-910. doi: 10.1093/aje/kwx323.
Parry C, Min SJ, Chugh A, Chalmers S, Coleman EA Further application of the care transitions intervention: results of a randomized controlled trial conducted in a fee-for-service setting. Home Health Care Serv Q. 2009;28(2-3):84-99. doi: 10.1080/01621420903155924.
Peters LL, Boter H, Buskens E, Slaets JP Measurement properties of the Groningen Frailty Indicator in home-dwelling and institutionalized elderly people. J Am Med Dir Assoc. 2012 Jul;13(6):546-51. doi: 10.1016/j.jamda.2012.04.007. Epub 2012 May 12.
Rubenstein LZ, Harker JO, Salva A, Guigoz Y, Vellas B Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci. 2001 Jun;56(6):M366-72. doi: 10.1093/gerona/56.6.m366.
Stewart AL, Nápoles AM, Piawah S, Santoyo-Olsson J, Teresi JA Guidelines for Evaluating the Feasibility of Recruitment in Pilot Studies of Diverse Populations: An Overlooked but Important Component. Ethn Dis. 2020 Nov 19;30(Suppl 2):745-754. doi: 10.18865/ed.30.S2.745. eCollection 2020.
Tsoi KK, Chan JY, Hirai HW, Wong SY, Kwok TC Cognitive Tests to Detect Dementia: A Systematic Review and Meta-analysis. JAMA Intern Med. 2015 Sep;175(9):1450-8. doi: 10.1001/jamainternmed.2015.2152. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.